Episode 10 - Jason Lettmann, CEO ALX Oncology

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We’re excited to host Jason Lettmann, the CEO of ALX Oncology. Jason brings a wealth of experience from his roles as General Partner at Lightstone Ventures and CEO of Promedior Inc., where he led the company to a successful acquisition by Roche. With over a decade of leadership in biotech and venture capital, Jason is now steering ALX Oncology towards groundbreaking advancements in immuno-oncology. Join us as we dive into Jason's journey, the challenges and successes of ALX Oncology, and their innovative approach to cancer treatment. Welcome to the show, Jason! Enjoy and stay tuned!